Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer

BACKGROUND: Non‐small cell lung cancer (NSCLC) comprises the majority (~85%) of all lung tumors, with lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) being the most frequently diagnosed histological subtypes. Multi‐modal omics profiling has been carried out in NSCLC, but no studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaiparambil, Jose, Dong, Jianrong, Grimm, Sandra L., Perera, Dimuthu, Ambati, Chandra Shekar R., Putluri, Vasanta, Robertson, Matthew J., Patel, Tajhal D., Mistretta, Brandon, Gunaratne, Preethi H., Kim, Min P., Yustein, Jason T., Putluri, Nagireddy, Coarfa, Cristian, El‐Zein, Randa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844651/
https://www.ncbi.nlm.nih.gov/pubmed/35676822
http://dx.doi.org/10.1002/cam4.4933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844651/
https://www.ncbi.nlm.nih.gov/pubmed/35676822
http://dx.doi.org/10.1002/cam4.4933

Ejemplares similares